Rosetta Genomics (ROSG) to Sell Ordinary Shares, Warrants for Net Proceeds of $4.5M
Tweet Send to a Friend
Rosetta Genomics Ltd. (NASDAQ: ROSG) today announced that it has received commitments from certain institutional investors to purchase approximately $5.1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
